Earnings Outlook For Spero Therapeutics
Portfolio Pulse from Benzinga Insights
Spero Therapeutics (NASDAQ:SPRO) is expected to release its quarterly earnings report on Monday, 2023-11-13, with an estimated EPS of $-0.03. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, Spero's stock price has reacted negatively to past earnings reports, even with an EPS beat last quarter. Over the last year, SPRO shares have declined by 45.81%, indicating dissatisfaction among long-term shareholders.
November 10, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Spero Therapeutics is anticipated to report quarterly earnings with an EPS estimate of $-0.03. Investors are focused on potential earnings beat and future guidance. The stock has historically reacted negatively post-earnings, with a 45.81% decline over the past year.
The short-term impact on SPRO's stock price will likely hinge on whether the company beats the EPS estimate and provides positive guidance. However, given the stock's negative reaction to past earnings, even with an EPS beat, and the overall 45.81% decline over the past year, investor sentiment may remain cautious. The score is neutral due to the uncertainty of the market's reaction to the earnings report and guidance.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100